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Foveal hypoplasia is a congenital disorder characterized 
by absent or abnormal foveal or macular reflexes, unclear 
definition of the foveomacular region, and a poorly defined 
foveal avascular zone. Foveal hypoplasia is commonly found 
in association with other eye conditions, including albinism 
(OMIM 203100 and 300500), achromatopsia (OMIM 216900), 
aniridia (OMIM 106210), retinopathy of prematurity, and 
incontinentia pigmenti (OMIM 308300) but has also been 
reported as an isolated feature [1-3].
We have previously described two families with unique 
phenotypes involving foveal hypoplasia. The first family 
(F1) is a consanguineous British family of Pakistani origin 
who presented with multiple cases of foveal hypoplasia and 
anterior segment dysgenesis (Figure 1A) [4]. The anterior 
segment abnormalities observed were posterior embryotoxon 
(all affected patients) and Axenfeld’s anomaly (IV:1 and IV:7 
in Figure 1). By performing a whole genome linkage search, 
we mapped a recessive gene for this disorder to a 6.5 Mb 
interval on chromosome 16q23.2–24.2. This locus is flanked 
by markers D16S3098 and D16S2621, and multipoint linkage 
analysis generated a maximum logarithm of the odds (LOD) 
score of 5.51 [4]. The second family (F2) is from Afghani-
stan and is also consanguineous (Figure 2). The two affected 
females presented with foveal hypoplasia and chiasmal 
misrouting but showed no other signs of albinism [5].
In this study, we extend the clinical phenotypes observed 
in each family and show that they have the same disorder, 
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Purpose: We have previously described two families with unique phenotypes involving foveal hypoplasia. The first 
family (F1) presented with foveal hypoplasia and anterior segment dysgenesis, and the second family (F2) presented 
with foveal hypoplasia and chiasmal misrouting in the absence of albinism. A genome-wide linkage search in family F1 
identified a 6.5 Mb locus for this disorder on chromosome 16q23.2–24.1. The aim of this study was to determine if both 
families have the same disorder and to see if family F2 is also linked to the 16q locus.
Methods: Family members underwent routine clinical examination. Linkage was determined by genotyping microsatel-
lite makers and calculating logarithm of the odds (LOD) scores. Locus refinement was undertaken with single nucleotide 
polymorphism (SNP) microarray analysis.
Results: The identification of chiasmal misrouting in family F1 and anterior segment abnormalities in family F2 sug-
gested that the families have the same clinical phenotype. This was confirmed when linkage analysis showed that family 
F2 also mapped to the 16q locus. The single nucleotide polymorphism microarray analysis excluded a shared founder 
haplotype between the families and refined the locus to 3.1 Mb.
Conclusions: We report a new recessively inherited syndrome consisting of foveal hypoplasia, optic nerve decussation 
defects and anterior segment dysgenesis, which we have abbreviated to FHONDA syndrome. The gene mutated in this 
disorder lies within a 3.1 Mb interval containing 33 genes on chromosome 16q23.3–24.1 (chr16:83639061 - 86716445, 
hg19).
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which we have termed foveal hypoplasia, optic nerve decus-
sation defects and anterior segment dysgenesis (FHONDA 
syndrome). Through genetic studies, we present data 
suggesting that the same gene is mutated in the two families 
and refine the previously published 16q locus to a 3.1 Mb 
interval containing 33 genes.
Figure 1. Clinical results of family F1. A: Pedigree of family F1. Individuals represented by solid symbols have been confirmed as affected 
by clinical examination. B: Ocular coherence tomography (OCT) macular thickness data for family member IV:1 showing bilateral foveal 
hypoplasia in an otherwise normal retina. C: Fundus image showing foveal hypoplasia in family member IV:1. D: Flash visual evoked 
potential (VEP) results of IV:1 (upper panel) and IV:3 (lower panel) showing contralateral asymmetry of VEP. The arrow shows the N2 peak, 
which is similar to that seen in albinos. OD, right eye; OS, left eye. Note the time on the x-axis begins at time-point -15 ms.
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METHODS
Patients: Ethical approval was obtained from the Leeds East 
Teaching Hospitals Trust Research Ethics Committee, and 
informed consent was obtained for all subjects. Family F1 
is a UK family of Pakistani origin. Nineteen members were 
recruited for the study, eleven females and eight males. The 
ages of the affected individuals at recruitment ranged from 
4-14. Family F2 is a Dutch family of Afghan origin. Six 
members were recruited for the study, three males and three 
females. The ages of the affected individuals at recruitment 
were 16 and 10. All subjects were in good general health at 
the time of the recruitment. The research conducted in this 
study adhered to the tenets of the Declaration of Helsinki. 
Family F1 has been described in detail by Pal et al. [4]. Two 
members of family F2 were described by van Genderen et 
al. [5]. Detailed clinical examination of family members 
was undertaken. Blood samples for DNA extraction (2-6 ml 
depending on age) were collected by venepunture from the 
antecubital fossa and stored in BD vacutainer® EDTA blood 
collection tubes (BD Biosciences, Oxford UK). Skin color of 
the affected individuals was compared to that of the parents 
and unaffected siblings, and history was taken regarding the 
individuals’ skin color at birth.
Ophthalmic examination: The eye examinations of all 
patients included best-corrected visual acuity, slit-lamp 
biomicroscopy, and indirect ophthalmoscopy. Color vision 
was tested using Ishihara color plates. Ocular coherence 
tomography (OCT) scans of the macular area were obtained 
using a Stratus 3000 (Carl Zeiss Meditec, Jena, Germany). 
Visual evoked potential (VEP) tests were performed using 
International Society for Clinical Electrophysiology of Vision 
(ISCEV) standard protocols but with a brighter flash lumi-
nance. The VEP was recorded with a common reference elec-
trode at Fpz (10:20 system), from active electrodes at O3, Oz, 
and O4. The stimulus used was a Grass PS33+ stroboscope 
on setting 4 under scotopic conditions. The unstimulated eye 
was double-patched to exclude all light.
Linkage analysis: Genotyping was performed using fluores-
cently tagged microsatellite markers as described previously 
[6]. Briefly, standard PCR reactions were performed in a 25 μl 
volume containing 50 ng genomic DNA using Invitrogen Taq 
DNA polymerase and buffers (Invitrogen, Life Technologies 
Ltd, Paisley, UK). Twelve microsatellite markers (Table 1) 
surrounding the previously published 16q locus were selected 
from the UCSC Genome Browser. Following amplification, 
PCR products were resolved using an ABI 3730 xl DNA 
sequencer and analyzed using GeneMapper v 4.0 software 
from the same manufacturer (Applied Biosystems, Carlsbad, 
CA). Linkage analysis was performed under the assump-
tion of a recessive model with 100% penetrance and 0.0001 
frequency of the disease allele and equal marker allele 
frequencies. Multipoint linkage analyses were performed 
using Superlink [7]. The UCSC Genome Browser was used 
to determine the genetic distances.
Single nucleotide polymorphism microarray analysis: DNA 
from one affected member of each family was analyzed using 
Affymetrix 6.0 SNPchip. This analysis was performed with 
AROS Applied Biotechnology (Århus, Denmark). The results 
were analyzed using IBDfinder software [8].
Figure 2. Clinical and genotyping 
results for family F2. A: Pedigree 
of family F2. Haplotypes spanning 
16q23–24 are shown below each 
symbol. Each different haplotype 
block is represented by a different 
color with the disease haplotype 
colored black. B: Ocular coherence 
tomography (OCT) macular thick-
ness data for family member IV:5 
showing bilateral foveal hypoplasia 
in an otherwise normal retina. C: 
Slit-lamp result for IV:5 showing 
posterior embryotoxon (arrow).
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RESULTS
The presence of foveal hypoplasia in the absence of well-
recognized syndromes such as albinism and aniridia is rare. 
This prompted us to investigate whether families F1 and F2 
could have the same clinical disorder. To address this ques-
tion, both families underwent additional clinical examina-
tion. Electrophysiological testing to measure flash VEPs was 
performed in two members of family F1 (IV:1 and IV:3) to 
determine if they had any optic nerve misrouting defects. The 
results in Figure 1 show that both patients have a contralateral 
predominance indicating increased crossover at the level of 
the optic chiasm. Ocular coherence tomography analysis in 
these patients confirmed that they lacked a foveal pit but 
showed that the thickness and overall structure of the retina 
were normal (Figure 1). All affected members of this family 
have absent iris transillumination and have dark pigmented 
skin and hair, which has been present since birth, and is 
similar to that of their parents and siblings. Affected members 
of family F2 were reexamined for signs of anterior segment 
dysgenesis. Both members had posterior embryotoxon (Figure 
2). Thus, the two families have the same clinical phenotype 
of foveal hypoplasia, optic nerve decussation defects and 
anterior segment dysgenesis in the absence of albinism. 
We termed this new phenotype FHONDA syndrome. The 
clinical features found in patients with FHONDA syndrome 
are summarized in Table 2.
We previously mapped the recessive gene mutated in 
family F1 to a new locus on chromosome 16q [4]. To deter-
mine if the gene mutated in family F2 also mapped to this 
locus, we genotyped 12 microsatellites spanning this locus 
in family members. The haplotype data for these markers 
is shown in Figure 2. The order and Marshfield genetic 
location of these markers are as follows: 16cen – D16S511 
(110.4-cM) – D16S534 (111.12-cM) – D16S3091 (111.12-cM) 
– D16S402 (113.52-cM) – D16S2625 (120.59-cM) – D16S3061 
(121.45-cM) – D16S3037 (121.45-cM) – D16S539 (124.73-cM) 
– D16S476 (128.53-cM) – D16S3077 (127.99-cM) – D16S3048 
(127.99-cM) – D16S2621 (130.41-cM) −16qtel (genetic 
distances are taken from the chromosome 16p telomere). As 
the genetic position of marker D16S476 did not correlate with 
its physical position (determined from the genome sequence), 
we corrected the marker order and used the genetic position 
of 127.53-cM in our linkage analysis.
Affected individuals IV:2 and IV:5 from family F2 share 
a region of homozygosity from marker D16S402 to the end 
of the 16q telomere. To determine the significance of this 
finding, multipoint LOD scores were generated using all 
markers. The results are shown in Figure 3. A maximum LOD 
score of 2 was generated with the telomeric 7 markers, which 
is the cutoff point for determining significant linkage when 
testing a known locus.
To define the smallest region of homozygosity in each 
family, DNA from a single affected individual from each 
family was processed using whole-genome single nucleotide 
polymorphism (SNP) microarrays (Affymetrix 6.0). These 
results refined the region of homozygosity in family F1 to an 
area between the markers D16S505 and rs11863161, and the 
region in family F2 to that between SNP rs8059833 and the 
end of 16q. No shared haplotype between the families was 
evident, suggesting that each family has a different muta-
tion. By combining the SNP data of families F1 and F2, we 
refined the location of the FHONDA syndrome gene to a 3.1 
Mb interval containing 33 genes (chr16:83639061 - 86716445, 
hg19).
Table 1. MicrosaTelliTe priMer deTails
Microsatellite Forward primer (5′-3′) Reverse primer (5′-3′) Size (bp)
D16S511 CCCCGGAGCAAGTTCA CAGCCCAAAGCCAGATTA 182–222
D16S534 CAACAAAGCAAGACCCTGTC CATCTGCGGTTCTTTCCTC 294–364
D16S3091 GGGAGATAGCCTTAAACTTTCTTAC TGTTGCTAATAACACTAGGCCA 115–129
D16S402 TTTTGTAACCATGTACCCCC ATTTATAGGGCCATGACCAG 161–187
D16S2625 TACGCAAGTCAAAGAGCCTC GGACACATGAGACCCTGTCT 183
D16S3061 CTACTGGTGAGGCTGAGGTG ATATCTCGGGATTTGTTGCTTTAC 241–253
D16S3037 GAGCCAAGATGACACCACT GCACTGGGAACCTAAGGA 201–217
D16S539 GATCCCAAGCTCTTCCTCTT ACGTTTGTGTGTGCATCTGT 157
D16S476 TTGCACTCCACTCTGGGCA TTGCCTTGGCTTTCTGTTGG 144–181
D16S3077 AGCAAGCCGTGACTGGGT CATGAGTAGTGTCCTGGGGG 253–267
D16S3048 AGCAAGCCGTGACTGGGT CATGAGTAGTGTCCTGGGGG 253–267
D16S2621 GTCATATGGGCCAATTCCC TACCGCGTAGTGAGACTGTG 239–263
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DISCUSSION
In this study, we defined a new disorder called FHONDA 
syndrome comprising foveal hypoplasia, optic nerve decus-
sation defects and anterior segment abnormalities. Combined 
foveal hypoplasia and optic nerve decussation defects have, 
up to now, been exclusively found in albinism. Although the 
anterior segment abnormality posterior embryotoxon is not a 
well-reported feature, studies have shown that 30% of ocular 
albinism cases have this feature [9,10]. However, none of the 
patients reported in this study have skin or ocular pigmen-
tation defects and have absent iris transillumination. This 
suggests that FHONDA syndrome is not a variant of albinism 
or caused by a defect in the melanin biosynthesis pathway. 
Nevertheless, pigmentation defects in albinism can be diffi-
cult to detect. Mutation screening in a cohort of patients with 
autosomal recessive ocular albinism showed that at least 69% 
(26/36) had mutations within the oculocutaneous albinism 
genes, particularly TYR, but the mild cutaneous pigmentation 
defects in these patients had been missed at diagnosis [11]. 
Similarly, patients with mutations in the ocular albinism gene, 
OA1, but without the classic ocular pigmentation defects have 
been reported [12-16]. In both instances, the lack of hypopig-
mentation has been attributed to factors such as hypomorphic 
alleles, genetic background, and/or environmental factors that 
modify this aspect of the phenotype [11,17]. Thus, we cannot 
categorically rule out that FHONDA syndrome is allelic 
with albinism and that similar modifier factors influence 
the pigmentation, especially as we report only two families 
of Asian origin. Therefore, once the mutated gene has been 
identified, it should be screened in a cohort of patients with 
mutation-negative albinism. A recent mutation screen of the 
known albinism genes in a cohort of Danish patients with 
albinism showed that they accounted for only 48% (10/21) 
of the patients with autosomal recessive ocular albinism, 
indicating that new genes remain to be identified [17].
Through a combination of microsatellite and SNP geno-
typing, the gene mutated in both families with FHONDA has 
been mapped to the same telomeric region of chromosome 
16q. This region contains only 33 genes, but none are obvious 
candidates apart from the forkhead box C1 gene, which has 
previously been excluded as the FHONDA gene [4]. The 
mechanism underlying optic nerve decussation at the chiasm 
has been an intensively studied model for neuronal patterning 
and guidance [18,19]. Similarly, foveal development has been 
studied as this highly specialized area of the eye underlies the 
majority of human visual function [20]. Over the years, these 
studies have implicated several molecules that individually 
Figure 3. Multipoint graph showing linkage to the foveal hypoplasia, optic nerve decussation defects and anterior segment dysgenesis locus 
in family 2. The approximate position of the locus published by Pal et al. is shown above the graph [4]. Logarithm of the odds (LOD) scores 
above 2 are statistically significant for linkage when testing is limited to one known locus.
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influence the development of these structures, but only those 
involved in the melanogenesis pathway have been shown to 
impact the development of both. Presumably, the presence of 
melanin in the retinal pigment epithelium influences the tran-
scription of several retinal genes, but the exact mechanism 
remains unknown. The identification of the gene mutated 
in FHONDA syndrome will hopefully shed light on these 
processes and provide a new melanin-independent aspect to 
this research.
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